Contents

Recent Patents on CNS Drug Discovery (Discontinued), Volume 5 - Number 3

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders

, 5(3): 182 - 194

Mariacristina Siotto, Serena Bucossi and Rosanna Squitti


DOI: 10.2174/157488910793362395




Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases

, 5(3): 195 - 202

Antonio Martin, Giulia De Vivo, Mariangela Ricotta, Maura Iannuzzi and Vittorio Gentile


DOI: 10.2174/157488910793362430




Current Options in the Treatment of Mitochondrial Diseases

, 5(3): 203 - 209

Mauro Scarpelli, Maria Sofia Cotelli, Michelangelo Mancuso, Giuliano Tomelleri, Paola Tonin, Carla Baronchelli, Valentina Vielmi, Valeria Gregorelli, Alice Todeschini, Alessandro Padovani and Massimiliano Filosto


DOI: 10.2174/157488910793362412




PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling

, 5(3): 210 - 220

Lindsay H. Burns and Hoau-Yan Wang


DOI: 10.2174/157488910793362386




Pharmacological Therapy of Parkinsons Disease: Current Options and New Avenues

, 5(3): 221 - 238

Nicola Simola, Annalisa Pinna and Sandro Fenu


DOI: 10.2174/157488910793362421




On the Future Development of Optimally-Sized Lipid-Insoluble Systemic Therapies for CNS Solid Tumors and Other Neuropathologies

, 5(3): 239 - 252

Hemant Sarin


DOI: 10.2174/157488910793362403




Neurogenic Drugs and Compounds

, 5(3): 253 - 257

Philippe Taupin


DOI: 10.2174/157488910793362377




Patent Selections:

, 5(3): 258 - 261

Bentham Science Publishers


DOI: 10.2174/157488910793362368




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science